BCAX Bicara Therapeutics Inc.

NASDAQ
$23.90

Bicara Therapeutics Inc. (BCAX) Institutional Ownership

What the institutions did with BCAX last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
178
filed a 13F this quarter
Managers holding
167
+26 on the quarter
Buyers
103
37 opened new
Sellers
49
11 sold out entirely
Buyer share
67.8%
of managers who traded it
Breadth
+35.5
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
RA CAPITAL MANAGEMENT, L.P. 7.3M 10.1%
T. Rowe Price Investment Management, Inc. 6.3M 8.8%
Siren, L.L.C. 5.6M 7.8%
Vestal Point Capital, LP 5.3M 7.3%
Deep Track Capital, LP 4.1M 5.7%
BlackRock, Inc. 3.8M 5.3%
Jupiter Topco LLC 3.2M 4.4%
RED TREE MANAGEMENT, LLC 3.2M 4.4%
TPG GP A, LLC 3.0M 4.2%
Royalty Pharma Sub-Manager, LLC 2.4M 3.3%
VANGUARD CAPITAL MANAGEMENT LLC 2.2M 3.1%
STATE STREET CORP 2.0M 2.8%
FRANKLIN RESOURCES INC 2.0M 2.7%
PRICE T ROWE ASSOCIATES INC /MD/ 1.9M 2.6%
FMR LLC 1.9M 2.6%
Omega Fund Management, LLC 1.8M 2.5%
GEODE CAPITAL MANAGEMENT, LLC 1.2M 1.6%
JPMORGAN CHASE & CO 1.0M 1.4%
Jones Hill Capital LP 892.6K 1.2%
ACORN CAPITAL ADVISORS, LLC 643.4K 0.9%
Aisling Capital Management LP 568.9K 0.8%
Palo Alto Investors LP 550.4K 0.8%
Rock Springs Capital Management LP 535.3K 0.7%
GOLDMAN SACHS GROUP INC 520.6K 0.7%
D. E. Shaw & Co., Inc. 498.2K 0.7%

Largest changes

Manager Action Previous Current Change
Royalty Pharma Sub-Manager, LLC New 0 2.4M +2.4M
CITADEL ADVISORS LLC Reduced 1.7M 211.1K -1.4M
Atle Fund Management AB Reduced 1.2M 145.7K -1.0M
BlackRock, Inc. Increased 2.8M 3.8M +1.0M
JPMORGAN CHASE & CO Increased 177.4K 1.0M +838.6K
STATE STREET CORP Increased 1.4M 2.0M +629.5K
FIL Ltd Reduced 679.9K 62.2K -617.7K
Omega Fund Management, LLC Reduced 2.4M 1.8M -570.0K
PRICE T ROWE ASSOCIATES INC /MD/ Increased 1.4M 1.9M +528.1K
ORBIMED ADVISORS LLC Reduced 667.3K 191.1K -476.2K
VANGUARD CAPITAL MANAGEMENT LLC Increased 1.8M 2.2M +442.4K
Jones Hill Capital LP Reduced 1.3M 892.6K -367.5K
DIMENSIONAL FUND ADVISORS LP Increased 109.3K 461.7K +352.5K
GEODE CAPITAL MANAGEMENT, LLC Increased 830.9K 1.2M +331.7K
FRANKLIN RESOURCES INC Increased 1.6M 2.0M +330.2K
AMERIPRISE FINANCIAL INC Increased 15.8K 288.7K +272.9K
T. Rowe Price Investment Management, Inc. Reduced 6.6M 6.3M -267.3K
Walleye Capital LLC Increased 108.0K 353.2K +245.2K
SEB Asset Management AB New 0 232.2K +232.2K
D. E. Shaw & Co., Inc. Increased 276.9K 498.2K +221.3K
FMR LLC Reduced 2.1M 1.9M -207.9K
Siren, L.L.C. Reduced 5.8M 5.6M -200.0K
Vestal Point Capital, LP Reduced 5.4M 5.3M -175.0K
NORTHERN TRUST CORP Increased 255.6K 396.3K +140.8K
MORGAN STANLEY Reduced 421.2K 283.9K -137.3K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.